Aberdeen Group’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.2M Sell
1,139,530
-61,280
-5% -$1.3M 0.04% 355
2025
Q1
$23.2M Sell
1,200,810
-89,615
-7% -$1.73M 0.05% 359
2024
Q4
$23M Buy
1,290,425
+154,139
+14% +$2.75M 0.04% 337
2024
Q3
$24.9M Buy
+1,136,286
New +$24.9M 0.05% 343